Therapeutic Options for Patients with TP53 Deficient Chronic Lymphocytic Leukemia: Narrative Review

Therapeutic Options for Patients with TP53 Deficient Chronic Lymphocytic Leukemia: Narrative Review

Paulina Stefaniuk,1 Julia Onyszczuk,2 Agnieszka Szymczyk,3 Monika Podhorecka1 1Department of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, Lublin, Poland; 2Students Scientific Association, Department of Haematooncology and Bone Marrow Transplantation, Medical Univers...

Full description

Bibliographic Details
Main Authors:	Stefaniuk P, Onyszczuk J, Szymczyk A, Podhorecka M
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-02-01
Series:	Cancer Management and Research
Subjects:	chronic lymphocytic leukemia p53 protein molecular aberrations drug resistance
Online Access:	https://www.dovepress.com/therapeutic-options-for-patients-with-tp53-deficient-chronic-lymphocyt-peer-reviewed-article-CMAR

Similar Items

Clinical significance of TP53 aberrations and IGHV mutational status in chronic lymphocytic leukemia
by: Tomić Kristina, et al.
Published: (2020-01-01)

Impact Of TP53 Gene Promoter Methylation On Chronic Lymphocytic Leukemia Pathogenesis And Progression
by: Saeed WH, et al.
Published: (2019-11-01)

Chronic lymphocytic Leukemia and deletionof the TP53 gene: Case report and literature review
by: Ucroz-Benavides, Andrea Carolina, et al.
Published: (2021-10-01)

Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods
by: Maria de Lourdes L.F. Chauffaille, et al.
Published: (2020-07-01)

Biological Prognostic Markers in Chronic Lymphocytic Leukemia
by: Vladimíra Vroblová, et al.
Published: (2009-01-01)

Immunohistochemical study of p-53 protein expression in chronic lymphocytic leukemia and its correlation with clinicopathological factors
by: Abdulrazzaq W. Abdullah, et al.
Published: (2015-04-01)

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
by: Miguel Quijada‐Álamo, et al.
Published: (2021-02-01)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
by: Paola Monti, et al.
Published: (2020-10-01)

mRNA in situ hybridization analysis of p-53 cancer suppression gene and Bcl-2 oncogene in chronic lymphocytic leukemia
by: Abdulkareem M. Jaafar, et al.
Published: (2010-07-01)

Monosomy 12 and deletion of 13q34 in a case of chronic lymphocytic leukemia with concomitant lung cancer
by: Antić Darko, et al.
Published: (2010-01-01)

The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies – A Narrative Review
by: Stefaniuk P, et al.
Published: (2020-04-01)

Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis
by: Kolquist Kathryn A, et al.
Published: (2011-11-01)

Overview of recent developments in chronic lymphocytic leukemia
by: Preetesh Jain, et al.
Published: (2012-01-01)

New Recurrent Structural Aberrations in the Genome of Chronic Lymphocytic Leukemia Based on Exome-Sequencing Data
by: Adrián Mosquera Orgueira, et al.
Published: (2019-09-01)

Therapeutic advancement of chronic lymphocytic leukemia
by: Lu Kang, et al.
Published: (2012-09-01)

Higher frequencies of chromosomal aberrations in lymphocytes of children with acute lymphoblastic leukemia after in vitro gamma irradiation
by: Azimi C, et al.
Published: (2012-12-01)

TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia
by: Keiichi Akizuki, et al.
Published: (2020-01-01)

RAS and TP53 can predict survival in adults with T‐cell lymphoblastic leukemia treated with hyper‐CVAD
by: Ali Sakhdari, et al.
Published: (2020-02-01)

Serum Survivin and TP53 Gene Expression in Children with Acute Lym-phoblastic Leukemia
by: Mohamed D Abd ElMaksoud, et al.
Published: (2012-01-01)

Serum Survivin and TP53 Gene Expression in Children with Acute Lym-phoblastic Leukemia
by: Raida S Yahya, et al.
Published: (2012-01-01)

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
by: Matteo Molica, et al.
Published: (2021-02-01)

Fludarabine induces apoptosis in chronic lymphocytic leukemia - the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins
by: J.R. Faria, et al.
Published: (2006-03-01)

Assessment of microRNA expression in leukemic cells as predictors of sensitivity to purine nucleoside analogs, fludarabine and cladribine, in chronic lymphocytic leukemia patients
by: Szymczyk A, et al.
Published: (2019-05-01)

p53 expression in chronic lymphocytic leukaemia
by: Nasir AL-Allawi, et al.
Published: (2005-07-01)

Relationship between chromosomal aberrations and gene expressions in the p53 pathway in chronic lymphocytic leukemia
by: Öztan G, et al.
Published: (2020-08-01)

Chromosome 17 abnormalities and mutation of the TP53 gene: correlation between cytogenetics, flow cytometry and molecular analysis in three cases of chronic myeloid leukemia
by: Luize Otero, et al.
Published: (2005-03-01)

Functional Classification of <i>TP53</i> Mutations in Acute Myeloid Leukemia
by: Sayantanee Dutta, et al.
Published: (2020-03-01)

Ibrutinib in the Treatment of Refractory Chronic Lymphocytic Leukemia
by: EA Nikitin, et al.
Published: (2017-07-01)

Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role
by: Alessandro Allegra, et al.
Published: (2020-02-01)

Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets
by: Giacomo Andreani, et al.
Published: (2020-03-01)

Prognosis and new therapeutic approaches in chronic lymphocytic leukemia treatment
by: Otašević Vladimir, et al.
Published: (2019-01-01)

Ofatumumab – a valid treatment option for chronic lymphocytic leukemia patients
by: AlDallal SM
Published: (2017-07-01)

Biclonal chronic lymphocytic leukemia: A study of two cases and review of literature
by: Kiran Ashok Ghodke, et al.
Published: (2017-01-01)

Cytogenetic Abnormalities with Interphase FISH Method and Clinical Manifestation in Chronic Lymphocytic Leukemia Patients in North-East of Iran
by: Hossein Rahimi, et al.
Published: (2016-12-01)

Identification of key pathways and genes in TP53 mutation acute myeloid leukemia: evidence from bioinformatics analysis
by: Huang R, et al.
Published: (2017-12-01)

THE USE OF MONOCLONAL ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA
by: Luca Laurenti
Published: (2013-04-01)

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia
by: Masternak M, et al.
Published: (2020-10-01)

Chronic lymphocytic leukemia in general practice
by: Đurović Ljiljana P.
Published: (2021-01-01)

An unusual presentation of chronic lymphocytic leukemia
by: Dinesh Atwal, et al.
Published: (2017-07-01)

An unusual presentation of chronic lymphocytic leukemia
by: Dinesh Atwal, et al.
Published: (2017-01-01)